SCHEMBL7703033

SCHEMBL7703033

CC(=O)Nc1ccc(O)c(Sc2ccc(C(=O)N[C@@H]3C4CCN(CC4)[C@H]3C)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.37
CHRNB2 P17787 2/20 0.36
CHRNA4 P43681 2/20 0.36
ALDH1A1 P00352 3/20 0.36
BLM P54132 1/20 0.36
MAPK14 Q16539 1/20 0.36
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.35
NAMPT P43490 1/20 0.35
SMYD3 Q9H7B4 1/20 0.34
HDAC1 Q13547 1/20 0.34
SLC6A9 P48067 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK4 Q16654 1/20 0.34
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6882524 0.88 CHRNA7 (0.47) CHRNA7L3MBTL1ALDH1A1TSHRNAMPT
SCHEMBL7564246 0.86 CHRNA7 (0.38) CHRNA7L3MBTL1CHRNB2CHRNA4ALDH1A1
SCHEMBL6883155 0.84 CHRNA7 (0.47) CHRNA7L3MBTL1CHRNB2CHRNA4ALDH1A1
SCHEMBL6872595 0.84 CHRNA7 (0.48) CHRNA7CHRNB2CHRNA4
SCHEMBL7706506 0.84 CHRNA7 (0.40) CHRNA7CHRNB2CHRNA4ALDH1A1BLM
SCHEMBL6878971 0.82 CHRNA7 (0.45) CHRNA7L3MBTL1ALDH1A1BLMMAPT
SCHEMBL6880056 0.82 CHRNA7 (0.43) CHRNA7L3MBTL1CHRNB2CHRNA4
SCHEMBL6879586 0.82 CHRNA7 (0.41) CHRNA7L3MBTL1CHRNB2CHRNA4ALDH1A1
SCHEMBL6873074 0.82 CHRNA7 (0.49) CHRNA7CHRNB2CHRNA4
SCHEMBL6884412 0.81 CHRNA7 (0.44) CHRNA7L3MBTL1CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486172-B2 ADMINISTERING TO A MAMMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF BENZAMIDE OR BENZOCARBONYLSULFIDE SUBSTITUTED 1-AZABICYCLO(2,2,2)OCT-3-YL COMPOUNDS TO TREAT THE CONDITIONS ASSOCIATED WITH DEFECTS OF NICOTINIC SUBTYPES BRAIN RECEPTORS PHARMACIA & UPJOHN COMPANY 2002-11-26 US claimed